Quality of life after laparoscopic and open retroperitoneal lymph node dissection in clinical Stage I nonseminomatous germ cell tumor: A comparison study

被引:52
作者
Poulakis, Vassilis
Skriapas, Konstantinos
de Vries, Rachelle
Dillenburg, Wolfgang
Ferakis, Nikolaos
Witzsch, Ulrich
Becht, Edward
机构
[1] NW Hosp, Dept Urol & Pediat Urol, D-60488 Frankfurt, Germany
[2] Stiftung Hosp Heiligen Geist, D-60488 Frankfurt, Germany
关键词
D O I
10.1016/j.urology.2006.01.023
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To compare the postoperative quality of life (QOL) and reconvalescence in patients with clinical Stage I nonseminomatous germ cell tumor (NSGCT) after laparoscopic retroperitoneal lymph node dissection (L-RPLND) and the open procedure (O-RPLND). Methods. Twenty-one patients with NSGCT who underwent transperitoneal L-RPLND were matched and compared with 29 patients who underwent O-RPLND. The operative, OOL, and recovery data and complications and cure rates were analyzed for both groups. Results. The mean follow-up time for the L-RPLND and O-RPLND groups was 14 months (range 6 to 20) and 26 months (range 8 to 38), respectively. No major complication requiring open surgical revision or prolongation of hospitalization was observed intraoperatively or postoperatively in either group. However, the early and late minor postoperative complications were significantly greater in the O-RPLND group than in the L-RPLND group (P < 0.001). The L-RPLND patients had a significantly shorter hospitalization, greater QOL scores, and a faster return to normal activities than did the O-RPLND patients (all P < 0.001). Conclusions. L-RPLND for patients with clinical Stage I NSGCT is a safe and efficacious procedure, with a faster reconvalescence and greater postoperative QOL than after O-RPLND.
引用
收藏
页码:154 / 160
页数:7
相关论文
共 22 条
[1]  
Albers Peter, 2002, Curr Opin Urol, V12, P435, DOI 10.1097/00042307-200209000-00012
[2]   Laparoscopic retroperitoneal lymph-node dissection in the management of clinical stage I and II testicular cancer [J].
Albqami, N ;
Janetschek, G .
JOURNAL OF ENDOUROLOGY, 2005, 19 (06) :683-692
[3]   Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer: current status [J].
Bhayani, SB ;
Allaf, ME ;
Kavoussi, LR .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (02) :145-148
[4]   Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: A long-term update [J].
Bhayani, SB ;
Ong, A ;
Oh, WK ;
Kantoff, PW ;
Kavoussi, LR .
UROLOGY, 2003, 62 (02) :324-327
[5]  
FAYERS P, 1998, EORTC QUALITY LIFE S
[6]  
Hobisch A, 1998, GERM CELL TUMOURS IV, P277
[7]   LAPAROSCOPIC RETROPERITONEAL LYMPHADENECTOMY - NEW APPROACH TO PATHOLOGICAL STAGING OF CLINICAL STAGE-I GERM-CELL TUMORS OF THE TESTIS [J].
HULBERT, JC ;
FRALEY, EE .
JOURNAL OF ENDOUROLOGY, 1992, 6 (02) :123-125
[8]   Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular carcinoma: Long-term outcome [J].
Janetschek, G ;
Hobisch, A ;
Peschel, R ;
Hittmair, A ;
Bartsch, G .
JOURNAL OF UROLOGY, 2000, 163 (06) :1793-1796
[9]   Laparoscopic retroperitoneal lymph node dissection [J].
Janetschek, G .
UROLOGIC CLINICS OF NORTH AMERICA, 2001, 28 (01) :107-+
[10]   Laparoscopic retroperitoneal lymph node dissection [J].
Janetschek, G ;
Peschel, R ;
Hobisch, A ;
Bartsch, G .
JOURNAL OF ENDOUROLOGY, 2001, 15 (04) :449-453